financetom
Business
financetom
/
Business
/
Doximity Stock Soars On Q1 Earnings: The Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Doximity Stock Soars On Q1 Earnings: The Details
Aug 8, 2024 2:22 PM

Doximity Inc ( DOCS ) reported financial results for its fiscal first quarter after the market close on Thursday. Here’s a look at the key metrics from the quarter.

What Happened: Doximity's ( DOCS ) first-quarter revenue increased 17% year-over-year to $126.68 million, beating the consensus estimate of $119.92 million, according to Benzinga Pro. The company reported adjusted earnings of 28 cents per share, beating analyst estimates of 22 cents per share.

Doximity ( DOCS ) generated operating cash flow of $41.2 million, down 28% year-over-year, and free cash flow of $39.5 million, down 29% year-over-year.

“We were pleased to deliver strong profits and record engagement last quarter, as we beat on both our top and bottom lines,” said Jeff Tangney, co-founder and CEO of Doximity ( DOCS ). “Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients.”

Doximity ( DOCS ) expects second-quarter revenue to be in the range of $126.5 million and $127.5 million versus estimates of $123.95 million. Doximity ( DOCS ) sees full-year 2025 revenue in the range of $514 million to $523 million versus estimates of $512.29 million.

Doximity ( DOCS ) expects first-quarter adjusted EBITDA of $62.5 million to $63.5 million. The company anticipates full-year adjusted EBITDA of $248.5 million to $257.5 million.

Management will discuss these results on a conference call slated for 5 p.m. ET.

See Also: SoundHound AI Q2 Earnings: Revenue Beat, EPS Beat, Raised Guidance On ‘Strong Customer Momentum’

DOCS Price Action: Doximity ( DOCS ) shares were up 23.07% after hours at $31.58 at the time of publication Thursday, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Seeks US FDA Approval for Subcutaneous Amivantamab for Certain Patients With Non-Small Cell Lung Cancer
Johnson & Johnson Seeks US FDA Approval for Subcutaneous Amivantamab for Certain Patients With Non-Small Cell Lung Cancer
Jun 17, 2024
08:51 AM EDT, 06/17/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that it had submitted a Biologics License Application to the US Food and Drug Administration for subcutaneous amivantamab for certain patients with non-small cell lung cancer. The company said the application is based on a late-stage study that showed that the subcutaneous form was as...
What's Going On With Workhorse Group Stock Monday?
What's Going On With Workhorse Group Stock Monday?
Jun 17, 2024
Workhorse Group Inc ( WKHS ) shares are in the spotlight Monday as the stock begins trading on a split-adjusted basis. Here’s a look at what you need to know. What To Know: Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company’s annual meeting of stockholders in May....
Aerovate scraps late-stage study for hypertension drug after mid-stage trial fails
Aerovate scraps late-stage study for hypertension drug after mid-stage trial fails
Jun 17, 2024
June 17 (Reuters) - Aerovate Therapeutics ( AVTE ) said on Monday it is shutting down the late-stage portion of a study testing its experimental hypertension drug after failing to meet the main goal in a mid-stage trial. ...
Quimbaya Gold Agrees to Buy New Mining Title in Segovia, Colombia
Quimbaya Gold Agrees to Buy New Mining Title in Segovia, Colombia
Jun 17, 2024
08:53 AM EDT, 06/17/2024 (MT Newswires) -- Quimbaya Gold ( QIMGF ) said on Monday that it agreed to buy an additional mining property with gold and silver exploration potential in Segovia, Colombia. As compensation for the concession contract, the company will pay US$205,000 ($281,892). As part of the deal, the company has agreed to pay US$50,000 at the signing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved